Veridex, LLC, a Johnson & Johnson company, is an organization dedicated to providing physicians with high-value in vitro diagnostic oncology products. Veridex's products may significantly benefit patients through earlier disease detection and may enable personalized strategies to help improve patient management and outcomes.

The company develops cancer diagnostic products that will enable earlier disease detection as well as monitoring and therapeutic selection. The company is initially developing two product lines: CellSearch^® assays that enumerate circulating tumor cells in blood and GeneSearch™ assays using molecular technology.

California Health Care Compliance information